Sun Protection in India Is Not a Luxury Problem. So Why Are We Treating It Like One?

India sits between 8° and 37° north latitude. For most of the country, for most of the year, the sun is not a background condition. It is an active, high-intensity environmental stressor. The UV Index across large parts of India routinely touches 10 or above during peak hours, a level the World Health Organization classifies as extreme, and one that can cause unprotected skin damage in as little as fifteen minutes (WHO, 2022).

And yet, sunscreen remains a product that most Indians do not use daily. Not because they are uninformed. But because somewhere along the way, the industry decided to sell it to the wrong people, for the wrong reasons, at the wrong price.

That decision has consequences. And it is worth examining honestly.

The Market Built the Wrong Story

Walk into any pharmacy or browse any skincare platform in India, and notice the language used to sell sunscreen. Anti-ageing. Brightening. Lightweight for the modern professional. Dermatologist-formulated. The imagery: fair-skinned women with dewy, aspirational skin. The price point: typically ₹400 to upwards of ₹1,000 for a full-sized bottle.

The message, decoded: sunscreen is for people who can afford to care about how they age.

This is a commercial framing, not a public health one. And the gap between those two things is costing people their skin health.

India's sunscreen market has historically been dominated by fairness and cosmetic positioning. Photoprotection in South Asian markets has been consistently framed around aesthetic outcomes: tanning prevention and complexion maintenance, rather than UV damage prevention or skin cancer risk reduction (Sachdeva, 2008; Narbutt et al., 2021). The result is a category that feels optional, a nice-to-have for women who care about ageing, not a baseline for anyone who goes outside.

The Myth That Darker Skin Doesn't Need It

There is a quieter reason sunscreen adoption remains low in India, and it lives in a belief so widespread it has almost attained the status of fact: that darker skin tones are naturally protected from UV damage.

This is partially true, and dangerously misunderstood.

Melanin does provide some inherent protection. Darker skin (classified as Fitzpatrick types IV through VI, which describes the majority of Indian skin) has a natural SPF estimated between 8 and 13 (Brenner & Hearing, 2008). That is meaningful. It helps explain lower rates of certain skin cancers in darker-skinned populations compared to type I and II skin.

But it does not mean protection is adequate. An SPF of 8 to 13 offers no meaningful defence against the cumulative UV damage that drives hyperpigmentation, melasma, photoageing, and over time, malignant change. It simply means the timeline is longer, not that the damage isn't happening.

What is particularly relevant for Indian skin is that UV-induced hyperpigmentation and melasma are among the most prevalent dermatological concerns in South Asian populations, and both are driven directly by unprotected sun exposure (Rajanala et al., 2019). The same exposure that the "you don't need sunscreen" myth encourages people to ignore.

Darker skin is not immune. It is differently vulnerable.

What the Numbers Actually Show

India records a lower incidence of cutaneous malignant melanoma compared to Western populations, a fact sometimes used to dismiss sun protection as unnecessary. But this framing is incomplete in two important ways.

First, non-melanoma skin cancers do occur in Indian patients, and when they do, they are frequently detected at more advanced stages, partly because of the assumption that darker skin is protected and partly because of limited dermatological access across many regions (Shrivastava et al., 2022). The issue is late detection, not absence of disease.

Second, the more immediate and widespread damage UV radiation causes in Indian skin is not cancer. It is chronic photodamage: pigmentation, inflammation, compromised barrier function, and accelerated structural ageing (Randhawa et al., 2015). These are not cosmetic vanities. They are evidence of skin under sustained assault, without adequate defence.

The public health cost of low sunscreen adoption in India is not hypothetical. It is visible daily, in the melasma that persists through multiple treatments because triggering exposure continues, in the post-inflammatory hyperpigmentation that deepens because nothing is blocking the UV that stimulates it, in the photoageing that accumulates quietly across decades of outdoor life without protection.

The Price Architecture of a Problem

Let's be direct about something the industry rarely says out loud: for a family on a middle-income budget in India, spending ₹600 to ₹800 monthly on sunscreen for daily reapplication, as clinically recommended, is not a realistic ask. Dermatologists advise reapplication every two hours of active sun exposure (WHO, 2022). A standard 50ml tube lasts perhaps two weeks under those conditions.

The pricing model of the premium sun care segment makes daily, adequate use economically inaccessible for the majority of the population with the highest sun exposure: outdoor workers, students commuting on two-wheelers, people in agriculture, construction, and informal labour.

These are not people who don't care about their skin. They are people who have been priced out of a product the industry positioned as luxury, then lectured about not using.

An accessible, honestly formulated SPF that doesn't trade on fairness aspirations or premium aesthetics, but is simply well-made and priced for daily use, is not a market gap. It is a public health gap dressed up as one.

Messaging That Protects, Not Aspirationally Upgrades

The UV index across India answers the question of whether sun protection is necessary. What remains is whether the industry is willing to have a fundamentally different conversation, one that separates protection from cosmetic aspiration, makes the science legible to everyone, and prices accordingly.

Broad-spectrum SPF 30 or higher, applied daily, has been shown in longitudinal research to meaningfully reduce cumulative photoageing, pigmentation irregularity, and skin cancer risk across all Fitzpatrick skin types when used consistently (Randhawa et al., 2015; Brenner & Hearing, 2008). The science is not ambiguous. The access is.

Sun protection messaging in India needs to stop asking: do you want to look younger and brighter? And start asking: do you spend time outside? Because if the answer to the second question is yes, and for most Indians it is, daily, then SPF is not a skincare step. It is the first one.

The luxury is not in the sunscreen. The luxury is in thinking you don't need it.

References

Back to blog

Leave a comment